Biogen Stocks Fall As They Tweak Their Research

 

The Biotechnology company Biogen is changing plans for their study on Alzheimer’s based on mid-study findings, making investors less confident. Based on their findings, 510 patients will need to be added to the final stage of the study. Biogen CMO Al Sandrock said, “ We did do a preplanned blinded sample size re-estimation. We did see more variability in the primary endpoint than assumed when we did the original sample size estimation, so we decided to increase the sample size to maintain 90% power. Therefore, we’re going to add 510 patients to the two studies.” With the recent changes and growing concerns for their stockholders, hopefully Biogens study will still pay off.

Follow us on social media for the latest updates in B2B!

Image

Latest

apprenticeship degree
Career-Connected Health Care: Why the Apprenticeship Degree Is the Future
April 13, 2026

Hospitals across the country are feeling the strain—too many open roles, not enough trained professionals, and a growing gap between what students learn and what the job actually demands on day one. Training is getting more expensive, timelines are stretching, and healthcare leaders are being forced to rethink how new clinicians enter the field….

Read More
Cybersecurity
The Expanding Threat Surface: Why Cybersecurity Is No Longer Optional for SMBs
April 9, 2026

Cybersecurity is no longer a concern reserved for large enterprises—it has become a defining issue for businesses of every size. Over the past decade, the rapid rise of cloud computing, artificial intelligence, and cryptocurrency has fundamentally reshaped the threat landscape, lowering the barrier to entry for cybercriminals and expanding the range of viable targets….

Read More
rubber
How Precision Engineering and Regulatory Complexity Shape the Future of Rubber Manufacturing
April 9, 2026

In an era where precision manufacturing often hides behind the simplicity of everyday products, the world of rubber components offers a striking reminder that complexity frequently lives beneath the surface. What appears to be a modest gasket or sealing element is, in reality, the product of highly specialized engineering, rigorous testing, and an…

Read More
tekniplex
Inside TekniPlex Gaggiano: How Specialized Manufacturing and Precision Engineering Define a True Center of Excellence
April 9, 2026

Manufacturing excellence today is less about scale alone and more about precision, control, and adaptability—especially in industries where even microscopic inconsistencies can have outsized consequences. As global supply chains grow more complex and regulatory standards tighten, facilities that invest in specialized processes and contamination control are quietly becoming the backbone of innovation. Segregated…

Read More